ERR4976615
— · D
Clinical attributes
From the source cohort, normalized into canonical keys plus the project's native columns.
- cancer_type
- —
- cancer_type_detailed
- —
- subtype
- D
- subtype
- D
- overall_survival_months
- 24
GSVA pathway preview (50 Hallmark scores)
Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.
Top 10 elevated
- KRAS_SIGNALING_DN+0.350
- SPERMATOGENESIS+0.340
- PANCREAS_BETA_CELLS+0.090
- BILE_ACID_METABOLISM+0.070
- HEDGEHOG_SIGNALING-0.020
- MYOGENESIS-0.020
- COAGULATION-0.080
- NOTCH_SIGNALING-0.080
- WNT_BETA_CATENIN_SIGNALING-0.080
- PEROXISOME-0.110
Top 10 suppressed
- TGF_BETA_SIGNALING-0.470
- TNFA_SIGNALING_VIA_NFKB-0.440
- UNFOLDED_PROTEIN_RESPONSE-0.440
- MYC_TARGETS_V1-0.430
- REACTIVE_OXYGEN_SPECIES_PATHWAY-0.430
- IL6_JAK_STAT3_SIGNALING-0.400
- OXIDATIVE_PHOSPHORYLATION-0.380
- PROTEIN_SECRETION-0.370
- MTORC1_SIGNALING-0.360
- ADIPOGENESIS-0.350
Patient twins — nearest pathway neighbors
10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.
6 twins match this tumor's tissue · 4 come from a different tissue of origin
| # | Sample | Cancer type | Subtype | cos similarity |
|---|---|---|---|---|
| 1 | BS_4GTESTSE | Ganglioglioma | — | 0.955 |
| 2 | SRR934787 | — | — | 0.953 |
| 3 | ERR4976613 | — | D | 0.953 |
| 4 | SRR26320081 | — | — | 0.951 |
| 5 | SRR1797231 | — | cohortSC | 0.949 |
| 6 | MDT-AP-3189 | Med | Medulloblastoma | 0.946 |
| 7 | SRR602927 | GTEX | — | 0.945 |
| 8 | SRR4195666 | — | — | 0.945 |
| 9 | SRR1478032 | GTEX | — | 0.944 |
| 10 | ERR4976608 | — | D | 0.944 |
Per-pathway drug coverage
For each elevated pathway in this tumor, the best-reversing drug across the catalog. Uncovered pathways = unmet need at pathway level for this one patient.
0 of 4 elevated pathways have at least one drug that meaningfully reverses them.
| Pathway (elevated) | tumor score | Best drug | reversal magnitude |
|---|---|---|---|
| KRAS_SIGNALING_DN | 0.350 | Remibrutinib | — uncovered |
| SPERMATOGENESIS | 0.340 | Inavolisib | — uncovered |
| PANCREAS_BETA_CELLS | 0.090 | Cobimetinib | — uncovered |
| BILE_ACID_METABOLISM | 0.070 | Inavolisib | — uncovered |